Stability of Immune Phenotype, Alloreactive, and Antiviral Immunity after Switch to Belatacept-Based Regimen after Kidney Transplantation

被引：0
|
作者：
Schaenman, J. [1 ]
Rossetti, M. [1 ]
Wilhalme, H. [1 ]
Groysberg, V. [1 ]
Sunga, G. [1 ]
Gadzhyan, J. [1 ]
Abdalla, B. [1 ]
Lum, E. [1 ]
Pham, P. [1 ]
Danovitch, G. [1 ]
Veale, J. [1 ]
Gritsch, H. A. [1 ]
Elashoff, D. [1 ]
Reed, E. [1 ]
Bunnapradist, S. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
226
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [41] Renal function impairment after islet transplant alone (ITA) or islet-after-kidney (IAK) transplantation using a sirolimus-tacrolimus-based regimen
    ACTA DIABETOLOGICA, 2005, 42 (01) : 52 - 53
  • [42] IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study
    Zeng, Jun
    Zhu, Daiwen
    Zhang, Haohan
    Lin, Tao
    Song, Turun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (03)
  • [43] Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
    Dharancy, Sebastien
    Coilly, Audrey
    Fougerou-Leurent, Claire
    Duvoux, Christophe
    Kamar, Nassim
    Leroy, Vincent
    Tran, Albert
    Houssel-Debry, Pauline
    Canva, Valerie
    Moreno, Christophe
    Conti, Filomena
    Dumortier, Jerome
    Di Martino, Vincent
    Radenne, Sylvie
    De Ledinghen, Victor
    D'Alteroche, Louis
    Silvain, Christine
    Besch, Camille
    Perre, Philippe
    Botta-Fridlund, Danielle
    Francoz, Claire
    Habersetzer, Francois
    Montialoux, Helene
    Abergel, Armand
    Debette-Gratien, Maryline
    Rohel, Alexandra
    Rossignol, Emilie
    Samuel, Didier
    Duclos-Vallee, Jean-Charles
    Pageaux, Georges-Philippe
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) : 2869 - 2878
  • [44] Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation
    Undre, NA
    van Hooff, J
    Christiaans, M
    Vanrenterghem, Y
    Donck, J
    Heeman, U
    Kohnle, M
    Zanker, B
    Land, W
    Morales, JM
    Andrés, A
    Schäfer, A
    Stevenson, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1299 - 1302
  • [45] Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
    Busque, Stephan
    Vincenti, Flavio G.
    Silva, Helio Tedesco
    O'Connell, Philip J.
    Yoshida, Atsushi
    Friedewald, John J.
    Steinberg, Steven M.
    Budde, Klemens
    Broeders, Emine N.
    Kim, Yon Su
    Hahn, Carolyn M.
    Li, Huihua
    Chan, Gary
    TRANSPLANTATION DIRECT, 2018, 4 (09):
  • [46] New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
    Santos, Alfonso H., Jr.
    Chen, Chao
    Casey, Michael J.
    Womer, Karl L.
    Wen, Xuerong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (01) : 177 - 184
  • [47] Next Generation Sequencing Based Analysis of the T-Cell Receptor Repertoire Reveals an Increase of Alloreactive T-Cell Clones after Kidney Transplantation
    Aschauer, C.
    Jelencsics, K.
    Hu, K.
    Reindl-Schwaighofer, R.
    Vetter, J.
    Heinzel, A.
    Kainz, A.
    Gualdoni, G.
    Schaller, S.
    Winkler, S.
    Oberbauer, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 638 - 638
  • [48] Effect of Everolimus-Based Immunosuppressive Regimen on New Onset of Diabetes After Kidney Transplantation - A 24 Month Subanalysis from the ELEVATE Study
    Holdaas, H.
    Chadban, S.
    de Fijter, J.
    Rostaing, L.
    Mancilla, U.
    Lopez, P.
    Bader, G.
    Cruzado, J.
    van der Giet, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 251 - 251
  • [49] The Impact of Immunosuppression on Mineral Metabolism One Year after Kidney Transplantation: Differences Between a Mycophenolate-Based Regimen Versus an mTOR Inhibitor-Based One
    Cucchiari, David
    Karam, Sabine
    Ventura-Aguiar, Pedro
    Diekmann, Fritz
    Torregrosa, Vicens
    TRANSPLANTATION, 2018, 102 : S656 - S657
  • [50] Bioinformatics-based analysis of the role of immune-related genes in acute rejection after kidney transplantation and renal cancer development
    Huang, Shan
    Yin, Hang
    MEDICINE, 2024, 103 (47)
12345